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This study compares the cross-sectional and longitudinal associations of cardiovascular risk
factors with clinical coronary heart disease (CHD) and with subclinical carotid atherosclerosis measured by
ultrasound. The study population were 1410 participants in the Atherosclerotic Risk in Community (ARIC)
Study (1987–1989) who also participated in a 1974 community health survey. Smoking in 1974 was associated




 2.2), whereas the corresponding
cross-sectional association was practically absent. For hypercholesterolemia and hypertension, the longitudinal
associations with CHD were also stronger than the cross-sectional associations. In contrast, the strength of the
longitudinal and cross-sectional associations with carotid atherosclerosis was generally similar. These results
underscore the advantages of using subclinical measures of atherosclerosis in cross-sectional studies. In addition,
they suggest that the presence of smoking, hypertension, or hypercholesterolemia in mid-adulthood may have






















Cohort studies have clearly established that hypercholes-
terolemia, cigarette smoking, and hypertension are inde-
pendent risk factors for clinical manifestations of athero-
sclerosis [1,2]. There have been recent cross-sectional
studies reporting the association between risk factors and
concurrent measurements of subclinical atherosclerosis [3–
6], but evidence regarding the longitudinal association be-
tween these risk factors and subclinical atherosclerosis is
limited [7,8]. The cross-sectional and longitudinal associa-
tions between risk factors and clinical coronary heart dis-
ease (CHD) have been compared [9,10], and a recent study
compared the cross-sectional and “time-integrated” mea-
surements of these risk factors in relation to carotid stenosis
in older adults [8]. To our knowledge, there are no studies
comparing such associations in middle-aged adults.
Using longitudinal information based on the linkage of
two population-based surveys conducted in Washington
County, Maryland, in 1974 and in 1987–1989, we investigated
and compared the longitudinal and the cross-sectional asso-
ciations of traditional risk factors with both clinical (self-
reported history of CHD) and subclinical atherosclerosis
[carotid intimal-medial thickness (IMT) or carotid plaque].
In addition, we also examined the associations between cer-







For the present study, a subset of participants from the
Washington County baseline cohort of the Atherosclerosis
Risk in Communities (ARIC) Study (1987–1989) [11]
were identified as participants in a 1974 county-wide survey
that collected information on cigarette smoking, blood
pressure, and serum cholesterol [12,13] (see Figure 1).
The ARIC Study is a prospective investigation of the
natural history and determinants of clinical and subclinical
atherosclerosis. As described in detail elsewhere [11], ap-
proximately 15,800 participants from four U.S. communi-
ties were first examined between 1987 and 1989. A total of
4020 participants were recruited in Washington County,
Maryland. Of these, 3694 (94% of those alive) returned 3 years
later for their second examination, conducted between
1990 and 1992 (Figure 1).
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Additional information came from a county-wide cam-
paign to collect blood for a serum bank, conducted by the
Johns Hopkins University Training Center for Public
Health Research in 1974 [14,15]. The campaign was nick-
named “operation CLUE” (for “Give us a clue to cancer”).
A total of 21,061 adult residents of Washington County
participated in this survey that included donating 15 mL of
blood. These individuals were interviewed and examined in
large trailers parked along the streets and roads of Washing-
ton County.
On the basis of exact matches on both birth date and
name (first and last, or maiden name among females), the
two datasets were linked. Exact matches (i.e., not allowing
for name misspellings) were required in order to maximize
the specificity of the matching criteria. Given the relatively
small size of the population frame (the total population of
Washington County is about 120,000), the occurrence of
false matches based on exact name and birth date is un-
likely. A total of 1410 individuals were identified among
participants in both the 1974 campaign and ARIC’s base-
line examination (Figure 1). Some of the results presented
here are based on this full cohort sample of 1410 partici-
pants in CLUE-ARIC (the results on smoking and hyper-
tension). The results related to hypercholesterolemia, are
based on a subset of 300 individuals among these 1410 per-
sons (case-control sample) who were included in a previous
cohort-based case-control study that involved thawing the
1974 serum samples to determine viral antibody levels [13].
These included 150 individuals with elevated carotid IMT
as determined by B-mode ultrasound (see later) as well as




Information on cigarette smoking, educational level, weight
at age 25 years, marital status, and medication use was ob-
tained by interview at the CLUE and the ARIC surveys.
For the CLUE (1974) survey, the time of the day for each
FIGURE 1. Study design: linkage between a countywide campaign to collect blood for a serum bank, conducted by the Johns Hopkins
University Training Center for Public Health Research (CLUE) and Atherosclerosis Risk in Communities (ARIC) surveys and time
and sources of information on risk factors (in italics) and outcomes (in bold). Abbreviations: CHD, coronary heart disease; CVD, car-
diovascular disease; IMT, carotid intimal medial thickness
 




individual’s examination was variable; participants were
not fasting. On the other hand, blood pressure measure-
ments, anthropometry, and venipuncture at the ARIC ex-
amination (1987–1989) were carried out in the morning
after subjects had fasted for 12 hours. Anthropometric mea-
surements in ARIC were done with subjects wearing a






The blood pressure measurement procedures differed in
the 1974 (CLUE) and in the 1987–1989 (ARIC) examina-
tions [12]. Briefly, in the 1974 CLUE survey, a nurse took
three sitting blood pressure measurements with a standard
mercury sphygmomanometer after the participant had been
resting for several minutes; the lowest value of the three
measurements was recorded. In the 1987–1989 ARIC ex-
amination, technicians used a random-zero sphygmoma-
nometer to take three sitting blood pressure measurements
after 5 minutes of rest; the average of the second and third
measurements was recorded. Total cholesterol was mea-
sured by enzymatic methods [16] in both surveys. A choles-
terol determination at the time of the 1974 survey was only
available in the subset of 300 participants comprising the
case-control sample (as already described).
 
Definition of Risk Factors and Outcomes
 
Among the main CVD risk factors, diabetes was not con-
sidered in the present report because the information was
not available at the time of the CLUE survey. Hypertension
at either the CLUE or the ARIC examinations was defined









 90 mmHg, or use of antihypertensive medica-
tion. Hypercholesterolemia in the CLUE survey (before the
wide availability of lipid-lowering medications) was simply




 240 mg/dL, whereas in




 240 mg/dL or
use of lipid-lowering medication. Educational level and
marital status at the time of CLUE, as well as an indicator
of adult weight change (based on self-reported weight at
age 25 years and measured weight at the time of ARIC),
were investigated as possible predictors of risk-factor status
change.
Clinical CHD was assessed at ARIC visit 1 based on a
self-reported physician-diagnosed heart attack, or history of
coronary procedures. Presence of subclinical atherosclerotic
disease was based on B-mode ultrasound examination of the
carotid arteries by trained sonographers following a stan-
dardized protocol [11,17]. Measurements of the IMT of the
far wall of the carotid arteries were taken at the common,
bifurcation, and internal carotids in both sides of the neck.
The ultrasound images were recorded on videotapes and
sent to the central ARIC Ultrasound Reading Center at
Bowman Gray School of Medicine, Winston-Salem, North
Carolina, where trained personnel read them. Estimates of
correlation between scans conducted 7–10 days apart in the
same individual, by different sonographers, and read by dif-
ferent readers, ranged from 0.70 to 0.77 for the different ca-
rotid sites [18]. The average IMT (expressed in millimeters)
of all measurements of the carotid far wall at all sites at
both ARIC examinations was used as a marker of carotid
atherosclerosis. The reason to average IMT measurement
over both examinations was to maximize reliability.
In addition, the presence of carotid plaque at any of the
examined sites in either examination was qualitatively as-
sessed by the ultrasound reader, based on the presence of a
lesion accompanied by acoustic shadowing at any of the ex-
amined sites [19]. A lesion was recorded if two of the fol-
lowing conditions were met: (a) wall shape: protrusion into
the lumen, loss of alignment with adjacent arterial bound-
ary, or roughness of the arterial boundary; (b) wall texture:
brighter echoes than adjacent boundaries; or (c) wall thick-
ness: IMT exceeding 1.5 mm. Acoustic shadowing was de-
fined as the reduction in amplitude of echoes caused by in-
tervening structures with high attenuation and is indicative
of mineral deposit within the plaque. Intrareader and inter-
reader agreement for the presence of plaque in any of the
six artery segments (kappa statistic) were 0.76 and 0.56, re-





Analysis of binary outcomes (change in risk-factor status,
prevalent clinical disease, carotid plaque) was carried out
using multiple logistic regression. Adjusted prevalence and
prevalence ratios (PR) were obtained from the logistic re-
gression prediction equation for each exposure category and
the average covariate values. Analysis of continuous out-
comes (baseline IMT) was conducted using multiple linear
regression models. For analyses of subclinical outcomes,
participants with history of heart attacks at the ARIC ex-
amination were excluded; the reason for this exclusion is to
assess the net association between risk factors and subclini-
cal atherosclerosis, avoiding the biases due to changes in
health behaviors or treatments subsequent to clinical events.
Because data on 1974 cholesterol levels were available only








 300), the 1974 and the
1987–1989 associations with hypercholesterolemia could
only be compared in this subset. Statistical analyses were
carried out using Statistical Analysis System (SAS) soft-




Of the 1410 participants, 559 (40%) were male. At the
time of the CLUE survey (1974), the median age of this co-
hort was 41 years (range, 29–51 years); at the first ARIC
examination, the median age was 55 years (range, 45–64
years). Table 1 shows the distribution and mean values of








ent time periods. The proportion of cigarette smokers de-
creased, whereas the proportion of participants with hyper-
cholesterolemia and the mean serum cholesterol levels
increased between the two time periods. Among individu-
als with cholesterol measurements available at both times
(including a high proportion of “atherosclerosis cases”; see
Methods), the average increase in serum cholesterol was
11.4 mg/dL. The apparent decrease in prevalence of hyper-
tension and mean arterial blood pressure is most likely an
artifact resulting from the different equipment and proce-
dures of blood pressure measurements in the 1974 and
1987–1989 surveys (see Methods).




5% of participants reported a history of a physician diag-
nosed heart attack or coronary surgery, and about 15% had
evidence of carotid plaque. Table 1 also shows the mean
BMI and mean carotid IMT at the ARIC examination.
The association between the presence of each of the
main risk factors in 1974 and the presence of the same risk
factor in the ARIC examination was very strong for each of
the risk factors considered (Table 2). The proportion of
participants affected in 1974 still exposed to the risk factor




60% for all three risk factors. In con-
trast, the prevalence in the latter examination was much
lower among those without the risk factor in 1974, particu-
larly for smoking. Pearson correlation coefficients between
1974 and 1987–1989 measurements were 0.52 for serum
cholesterol, 0.41 for systolic blood pressure, and 0.34 for di-
astolic blood pressure.
Table 3 shows the associations of selected baseline char-
acteristics and weight loss with new acquisition or persis-
tence of the three main risk factors. Both acquisition and
persistence of the smoking habit were associated with adult
weight loss. Smoking persistence was also significantly less
likely in males than in females. Persistent hypertension was
significantly associated with older age in 1974. Adult
weight gain was significantly related to both hypertension
acquisition and persistence. The results for hypercholester-
olemia are not shown in Table 3 because the numbers were
too small. Only 48 of 242 individuals newly developed hy-
percholesterolemia between 1974 and 1987–1989, and the




Characteristics of the cohort: Washington County participants in CLUE (1974)
and ARIC (1987–1989)
1974 1987–89
Number % Number %
 


















 high school 334/1306 25.6 370/1408 26.3









All — — 127/864 14.7
Excluding positive history of
heart attack or stroke — — 107/818 13.1
 
Number Mean Number Mean
 
Serum cholesterol (mg/dL) 299 207.1 1408 218.3
Systolic blood pressure (mmHg) 1409 130.8 1410 119.0
Diastolic blood pressure (mmHg) 1409 83.3 1409 71.2









All — — 1252 0.744
Excluding positive history of












When only the participants with cholesterol measured in 1974 were included (case-control sample), the pro-





























Mean intima-media wall thickness on all ultrasound measurements of the carotid arteries taken during visits 1




 ARIC, Atherosclerosis Risk in Communities; CLUE, a countywide campaign to collect blood
for a serum bank, conducted by the Johns Hopkins University Training Center for Public Health Research;
IMT, carotid intimal-medial thickness.
 








 2.4, 95% confi-
dence interval [CI] 1.4–4.1). Of the 57 individuals with hy-
percholesterolemia at baseline in the case-control subset
(Table 2), this condition persisted in 36 by 1987–1989, but
none of the risk factors analyzed in Table 3 was signifi-
cantly associated with its persistence (not shown).
The longitudinal and cross-sectional associations of
smoking and hypertension with both clinical and subclini-
cal atherosclerosis are compared in Table 4. For smoking,
the highest prevalence of clinical manifestations of athero-
sclerosis (history of heart attack or coronary surgery) was








 of new or persistent main cardio-
vascular risk factor at the ARIC visit (1987–1989) according to baseline characteristics
















































































Prevalence ratios for age and gender are each adjusted for each other; all other risk factors shown are adjusted




















Risk factor present in the ARIC examination (1987–1989) among those free of the risk factor at the time of
a countywide campaign to collect blood for a serum bank, conducted by the Johns Hopkins University Training




Risk factor present in the ARIC exam (1987–1989) among those with the risk factor at the time of CLUE








Based on weight change according to self-reported weight at age 25 and measured weight at the Atheroscle-
rosis Risk in Communities (ARIC) examination: weight loss represent a negative increment; weight gain is de-
fined as an increment of 20 kg or more; the reference category for these dummy variables is weight gain between



























Absent in 1974 989 963 26 2.6





Absent in 1974 840 679 161 19.2

















Absent in 1974 242 194 48 19.8




Prevalence of the risk factor in 1987–1989 in those with the risk factor in 1974 divided by prevalence of risk













The results for smoking and hypertension using the case-control subset were similar as those shown in the ta-












1974. Moreover, while a strong longitudinal association of





cross-sectional association (using only the smoking status




 1.2). In contrast,
for subclinical disease, there was little difference in the
strength of the longitudinal and cross-sectional associa-
tions, with the highest prevalence of carotid plaque and the
highest mean IMT among subjects reporting smoking at
both examination periods.
For hypertension, the results were similar to those of
smoking, in that a weak cross-sectional association with





significant). For subclinical outcomes, the longitudinal as-
sociations with hypertension were somewhat stronger than
the cross-sectional ones (Table 4).
Table 5 shows the data regarding the association between
hypercholesterolemia and cardiovascular disease (CVD)
outcomes among the 300 participants on whom cholesterol
levels were determined at both examination periods (the
case-control sample). As for smoking, the highest preva-
lence of clinical disease in this case was observed among
participants with hypercholesterolemia only in 1974, and
the cross-sectional association with clinical disease was ab-
sent. In contrast, the strength of the association with sub-





To our knowledge, this is the first epidemiologic study com-
paring the long-term and the concurrent associations of the
three main CVD risk factors (cigarette smoking, hyperten-
sion, and hypercholesterolemia) with both clinical and sub-
clinical atherosclerosis. This study extends similar analyses





comparing the cross-sectional and longitudinal associations
between hypertension and hypercholesterolemia with clini-
cal CHD in the Framingham cohort, as well as a subsequent
report from the Evans County study [10]. The present study




Age- and gender-adjusted prevalence of clinical and subclinical cardiovascular disease, and mean carotid IMT in














































Not present in 1974 or 1987–89 2.9 8.8 0.719
Only present in 1974 8.3* 11.5 0.757*










No 2.8 9.0 0.719





No 3.7 9.2 0.724





Not present in 1974 or 1987–89 2.1 7.2 0.714
Only present in 1974 6.0* 17.6* 0.755*
Only present in 1987–89 4.3 11.7 0.731





No 2.6 8.5 0.717





No 3.1 9.8 0.725








Defined by the presence of both plaque and shadow in visits 1 (1987–1989) or 2 (1990–1992) ultrasound examinations, among participants without an




Grand mean of all measurements at all sites in visits 1 (1987–1989) and 2 (1990–1992) ultrasound examinations, among participants without an ARIC





























 CI, confidence interval; IMT, intimal-medial thickness.
 




ings, adding cigarette smoking and comparing clinical and
subclinical outcomes.
One of the principle findings of this study is that the
presence of any of these traditional risk factors in 1974 is
strongly associated with both clinical and subclinical ath-
erosclerosis in the ARIC examination in 1987–1989. More-
over, for clinical atherosclerotic disease (heart attack or
coronary surgery) associations with earlier assessment of
risk factors were stronger than associations seen cross sec-
tionally in 1987–1989. The practically absent cross-sec-
tional association between current cigarette smoking or hy-
percholesterolemia and prevalent CHD (Tables 4 and 5)
could in part stem from “prevalence-incidence bias” [21],
for example, decreased survival post-CHD in those with,
compared to those without, the risk factor. Alternatively,
this observation may result from temporal bias (“reverse
causality”) due to changes in lifestyle after clinical manifes-
tations of coronary disease. The latter would be consistent
with the literature reporting changes in lifestyle habits
(e.g., quitting smoking and reducing intake of dietary fat)
in heart attack survivors [22,23]. Such changes will affect
studies in which the effect of these risk factor is assessed
cross sectionally.
Another intriguing finding is that presence of the risk
factor in 1974 only, was more strongly associated with clin-
ical atherosclerosis than when the risk factor was present in
both periods. It is possible that those who had the risk fac-
tor in 1974 and made successful effort to change their status
before 1987 were at particularly high risk to begin with, for
example, because of clustering of other risk factors and/or
comorbidity, and that that is why they made the effort. It is
also possible that this apparent stronger effect of the 1974
risk-factor status compared with its persistence might stem
from survival bias. Given that the present study was re-
stricted to participants in both the 1974 and 1987–1989
surveys, all the dropouts (including deaths) that occurred in
the interim period are excluded; thus, it is theoretically pos-
sible that the subset of participants with persistent risk fac-
tors at both times may include a larger proportion of indi-
vidual with particular resistance to these risk factors (e.g.,
lesser susceptibility stemming from genetic makeup or lack
of other contributing environmental risk factors). The pos-
sibility of survival bias is more theoretical than real in this
case, however, because given the young age of the partici-
pants at the inception of this cohort (median 41 years),
only a small number (we estimate less than 2%) will be ex-
pected to die between the surveys in this study. Further-
more, as both longitudinal and cross-sectional analyses pre-
sented here are restricted to survivors, we think it is
unlikely that this survival bias would differentially affect
both types of analyses, thus affecting the “internal” validity
of these comparisons.
The results for hypercholesterolemia should be inter-
preted with caution, given the peculiar nature of the subset
of participants used for these analyses (atherosclerosis cases
and controls). In fact, when the same cross-sectional analy-
sis was replicated in the entire ARIC cohort with nonmiss-















5 1410), the corresponding age-
gender–adjusted prevalence ratio of clinical CHD in rela-
TABLE 5. Age- and gender-adjusted prevalence of clinical and subclinical cardiovascular disease and mean carotid IMT in























Not present in 1974 or 1987–89 5.0 19.3 0.765
Only present in 1974 18.1* 40.5* 0.980*
Only present in 1987–89 7.4 37.4* 0.869*
Present in 1974 and 1987–89 5.2 34.6 0.952*
Present in 1974e No 5.7 23.0 0.785
(Longitudinal) Yes 9.4 1.6 (0.7–4.0) 36.7 1.6 (1.0–2.7) 0.961 22.4*
Present in 1987–1990 e No 6.4 21.6 0.783
(Cross-sectional) Yes 6.5 1.0 (0.4–2.5) 36.2 1.7 (1.0–2.7) 0.903 15.3*
aSelf-reported physician diagnosis of a heart attack or coronary surgery.
bDefined by the presence of both plaque and shadow in visits 1 (1987–1989) or 2 (1990–1992) ultrasound examinations, among participants without an
ARIC history of heart attack, coronary surgery, or stroke.
cGrand mean of all measurements at all sites in visits 1 (1987–1989) and 2 (1990–1992) ultrasound examinations, among participants without an ARIC
history of heart attack, coronary surgery, or stroke.
dHypercholesterolemia: total serum cholesterol $240 mg/dL or lipid lowering treatment.
eRegardless of the presence of the risk factor in the other examination.
*P , 0.05 compared with the category “Not present” or “No.”
Abbreviation: CI, confidence interval; IMT, intimal-medial thickness.
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tion to hypercholesterolemia was 1.6 in both cases. None-
theless, it is noteworthy that the discrepant longitudinal
vis-à-vis cross-sectional results obtained in our case-control
sample (Table 5) correspond almost exactly with the find-
ings of Friedman et al. [9] in the Framingham study, in
which the longitudinal association of baseline cholesterol
levels with incident clinical CHD contrasted with the prac-
tically absent cross-sectional association. Furthermore, for
hypertension, both our study and the earlier report from
Framingham [9] show that the cross-sectional association,
while slightly weaker than the longitudinal one, was still
present.
In contrast with the clinical outcomes, the cross-sec-
tional associations between risk factors and subclinical out-
comes (presence of plaque or average carotid IMT in those
without clinical CHD) were generally almost as strong as
those observed in the corresponding longitudinal analyses
(Tables 4 and 5). This pattern underscores the advantages
of using subclinical measures of atherosclerosis compared
with clinical outcomes when assessing cross-sectional asso-
ciations [3,24,25]. The subclinical character of the outcome
reduces the likelihood of disease-related prior changes in
the individual’s behavior or changes due to treatment that
greatly limit the interpretation of associations observed in
cross-sectional studies using clinical outcomes.
That the subclinical associations tended to be stronger
when the factor was present only in 1974 than when it was
present only concurrently with the ultrasound measure-
ment (Tables 4 and 5) suggests that an assessment of the
risk factor 15 years earlier may be more representative of its
long-term cumulative effects. It is hard to measure the cu-
mulative exposure to hypertension or hypercholester-
olemia. However, data related to smoking in this cohort is
compatible with this hypothesis. Mean lifetime cumulative
smoking (estimated by smoking history at the time of the
ARIC examination) was 33 pack-years in those who were
current smokers only in 1974 and only 23 pack-years for
1987–1989–only smokers. In addition, the presence of the
risk factor only in the latter examination, unless it is an er-
ror, means recent onset and, consequently, less time for it
to exert its harmful effects given the long latency process
characterizing atherosclerosis. On the other hand, those
who had the risk factor in 1974 but did not have it in 1987–
1989 may include relatively large numbers of persons who
quit smoking (or who had their high blood pressure or high
cholesterol controlled shortly before 1987–1989). Indeed,
for smoking, among individuals who reported in 1987–1989
that they had quit, of those who reported smoking in 1974,
30% had quit within 3 or less years prior to the ARIC ex-
amination, compared to 6% of those who were not smokers
in 1974.
Regardless of the preceding discussion, an important in-
ference from these results relates to the long-term impor-
tance of these risk factors. As evidenced by the stratified
analyses (Tables 4 and 5), those who were smoking, or hy-
pertensive, or hypercholesterolemic in early adulthood,
maintain substantial elevated risk of atherosclerosis (clini-
cal or subclinical) about 15 years later, even if they were no
longer exposed to the risk factor at the latter time. This
conclusion is also consistent with data from other prospec-
tive studies documenting the important long-term effects of
these risk factors [8,26–28].
As secondary objectives of the present study, we also
documented strong tracking of risk factors in the 15-year
period between the two surveys (Table 2). Moreover, we
examined the predictors of acquisition and/or persistence of
risk factors in the interim period between the surveys (Ta-
ble 3). Perhaps the most striking findings of these analyses
were the relation between weight loss in adulthood and ac-
quisition/persistence of smoking; conversely, acquisition or
persistence of hypertension was associated with adult
weight gain.
One of the main limitations of this study is the lack of in-
formation on the presence of CHD or level of atherosclero-
sis at the earlier survey (1974). This prevents us from drawing
firm conclusions regarding temporal associations. However,
given the relatively young age of this cohort in 1974 (range
29–51 years) and the evolving character of atherosclerosis,
it appears reasonable to assume a temporal relationship be-
tween the presence of the risk factor in 1974 and athero-
sclerosis measurements in 1987–1989.
Another potential limitation is that ultrasound measure-
ments of the carotid arteries are not necessarily a direct
measure of atherosclerosis per se. These measurements,
however, have been validated with in vitro observations
[17]. In addition, ultrasound assessment of the carotid arter-
ies has been shown to correlate with both prevalent and in-
cident CHD [19,29–31].
This study shows that cardiovascular risk factors track
throughout adulthood and have longstanding atherogenic
effects. These results confirm the critical importance of tar-
geting young adults in order to prevent the consequences of
atherosclerosis later in life.
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